Dicerna Pharmaceuticals Stock Is Estimated To Be Possible Value Trap

Retrieved on: 2021-04-25 20:03:45

Tags for this article:

Click the tags to see associated articles and topics

Dicerna Pharmaceuticals Stock Is Estimated To Be Possible Value Trap. View article details on hiswai:

Excerpt

Dicerna Pharmaceuticals has a cash-to-debt ratio of 10.90, which is in the middle range of the companies in Biotechnology industry. The overall ...

Article found on: www.gurufocus.com